University Hospital of North-Norway
The Research Group for Child and Adolescents Health at UiT the Arctic University of Norway (UiT)/University Hospital of Northern Norway (UNN) in Tromsø is working to gain new insights into the health and diseases of children and young people to contribute to improving preventive methods and treatments. Link: https://uit.no/research/pediatrics
The research group includes university employees and other researchers affiliated with the Child and Adolescent Health Department including the Child and Adolescent Psychiatric Department (UNN), as well as those with pure university positions linked to the Pediatric Research Laboratory at the Faculty of Health Science of the UiT. Clinical research is done i cooperation with the Clinicalo research department at UN
The strategy of the research group is based on the research strategy of the Faculty of Health Sciences, UiT, and UNN/Northern Norway Regional Health Authority.
Primary Goal (long-term)
Generate new knowledge about the somatic and mental health and diseases of children and youth to better prevent and treat them.
Research Fields
- Infections (biofilm, staphylococci, microbiome)
- Cancer (neuroblastoma, clinical cancer research)
- Rheumatology, neonatology
- Mental disorders
- Most projects involve collaboration with other groups on-site and internationally
Diversity
There is academic diversity in the research group, including representatives from various backgrounds:
- Natural scientist/engineer, physician
- Psychologist, nurse
- Research line student, master's student
- PhD candidate
- Postdoctoral researcher/researcher/associate professor
- Professor
Funding
Funding sources include internal funds from UNN/UiT, competitive grants from UNN/UiT, allocations from Helse Nord (somatic, mental, telemedical), grants from Norwegian Cancer Society, Norwegian Childhood Cancer Society, Norwegian Research Council, European Union etc.
Research sponsored by industry as well as by academic or other institutions are in Tromsø organised at one of the three clinical departments, Pediatric university lab and at the Clinical research department.
Personel
Several experienced nurses hold part-time positions related to research on children, with coordinator Malen Otelie Nørby. Senior consultant Trond Flægstad holds a part-time position related to NorPedMed. Additionally, we have several consultants in professorial positions and in associate professorial positions at the UiT, engaging in research.
The department has extensive experience in both researcher-initiated studies and industry-initiated clinical trials.
Professor Ellen Nordal (chair research committee of the Child and Adolescent Psychiatric Department (UNN)) and professor em/consultant at the Clinical research department.
Study nurse Tonje Løvli and coordinator Malen Otelie Nørby
Professor Claus Klingenberg, chair of the Research Group for Child and Adolescents Health at UiT the Arctic University of Norway (UiT)/University Hospital of Northern Norway (UNN)
Ongoing studies
| REK | Prosjekt | Status | Lenker |
|---|---|---|---|
| 2014/1633 | A Long-term Access Programme for Subjects With Severe Asthma Who Participated in a GSK-sponsored Mepolizumab Clinical Study | Ferdig | — |
| 2017/1373 | A Multi-center, Open-label, Single-arm, Before and After Switch Study to Evaluate the Efficacy, Safety and Tolerability of Alemtuzumab in Pediatric Patients with Relapsing Remitting Multiple Sclerosis (RRMS) with Disease Activity on Prior Disease Modifying Therapy (DMT) | Avsluttet | |
| 2017/661 | A Phase 1b, Open-label, Single-dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of MK-7655A in Pediatric Subjects From Birth to Less Than 18 Years of Age With Confirmed or Suspected Gram-negative Infections | Ferdig | |
| 2017/660//2018/2167 | A Phase 1, Single-Dose Safety and Pharmacokinetic Study of Oral and IV Tedizolid Phosphate (MK-1986) in Inpatients Under 2 Years Old | Ferdig | |
| 2019/566 | A Phase 3, Multicenter, Randomized, Double-blind, Active-comparator-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of a 3-dose Regimen of V114 in Healthy Infants (PNEU-PED-EU-2) | Ferdig | |
| 2017/1863 | The Norwegian Antibiotics for Pneumonia in Children Study (NAPiC) | Pågår | |
| 2018/1495 | INSTAR: Innovative steroid treatment to reduce asthma development in first-time rhinovirus induced wheezing | Pågår | — |
| 2014/1633 | A randomised, double-blind, placebo-controlled, parallel-group, multi-centre 24-week study to evaluate the efficacy and safety of mepolizumab adjunctive therapy in subjects with severe eosinophilic asthma on markers of asthma control | Ferdig | — |
-under contruction-
